Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pipeline Watch: Phase III Starts For Itacitinib And AXS-05

Jul 21 2017

• By John Davis

Pipeline Watch regular column feature image

Related Companies

Spark Therapeutics, Inc.

Beta Pharma, Inc.

ViiV Healthcare

PTC Therapeutics, Inc.

Roche Holding AG

Aerie Pharmaceuticals, Inc.

Theravance Biopharma Inc.

Viatris Inc.

Nektar Therapeutics

Paratek Pharmaceuticals, Inc.

Incyte Corporation

Axsome Therapeutics, Inc.

SynCore Biotechnology Co., Ltd

BrainStorm Cell Therapeutics Inc.

Kintara Therapeutics

AbbVie Inc.

Boehringer Ingelheim GmbH

Novartis AG

MorphoSys AG

Pharnext SA

Sio Gene Therapies, Inc.

Alzheon Inc.

Scinai Immunotherapeutics Ltd.

FUJIFILM Holdings Corp.

Vertex Pharmaceuticals Incorporated

CymaBay Therapeutics, Inc.

Ironwood Pharmaceuticals, Inc.

Cancer Prevention Pharmaceuticals, Inc.

Wave Life Sciences Ltd.

Achillion Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Puma Biotechnology, Inc.

LEO Pharma A/S

AstraZeneca PLC

Gedeon Richter Plc.

Recordati SpA

Novartis AG

Cardiome Pharma Corp.

Additional Topics

Approvals Research & Development Pipeline Watch BioPharmaceutical

More from Pipeline Watch

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window